Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0Journal of Biological Chemistry

SNX-BAR proteins 5 and 6 are required for NCOA7-AS antiviral activity against influenza A virus

Abstract

Interferon-induced antiviral proteins act on the first line of defence against viruses, including influenza A virus (IAV). Among those, the short isoform of Nuclear Receptor Coactivator 7 (NCOA7-AS) has been shown to inhibit IAV entry and more especially the fusion between endosomal and viral membranes. Ectopic expression of NCOA7-AS leads to the increased acidification of the endolysosomal pathway, putatively through NCOA7-AS interaction with the vacuolar ATPase (V-ATPase). However, the precise mechanism of action of NCOA7-AS is not fully understood. Here, we identified the cellular partners of NCOA7-AS by mass spectrometry, including the V-ATPase subunits known to interact with NCOA7-AS. A point mutation disrupting the interaction with the V-ATPase led to loss of antiviral activity against IAV, demonstrating that V-ATPase engagement is required for the antiviral phenotype. Moreover, sorting nexin (SNX) 1/2/5/6 were identified as novel partners of NCOA7-AS. These proteins are involved in retrograde transport of cellular cargoes from endosomes to the trans-Golgi network. We revealed that SNX5/6 interacted directly with NCOA7-AS and were essential for NCOA7-AS antiviral activity against IAV. Interestingly, crystal structures of NCOA7-AS/SNX5 complexes showed that the SNX5-interaction motif in NCOA7-AS was similar to those found in known cargoes of SNX5/6. In addition, we could pinpoint several critical residues that were important for binding and antiviral activity. Collectively, our study identifies novel essential partners for NCOA7-AS antiviral activity and the structural basis for their interaction.

Related

  1. Host-targeted repurposed diltiazem enhances the antiviral activity of direct acting antivirals against Influenza A virus and SARS-CoV-2
    Blandine Padey, Clément Droillard, Victoria Dulière +10
    Antiviral ResearchPeer-reviewedCC BY 4.0Full text5 citedMicrobiologyInfectious diseaseHAL
  2. The bisbenzimide compound ridinilazole has antiviral activity against vaccinia and mpox viruses.
    Misbah El-Jesr, Lucy Eke, Blair L. Strang +2
    The Journal of general virologyPeer-reviewedCC BYFull textMicrobiologyEurope PMCPMC
  3. Antiviral activity of Rumex crispus extract and its bioactive constituent emodin against human coronavirus OC43
    Seungju Cho, Jang Hoon Kim, Siyun Lee +5
    PLOS OnePeer-reviewedCC BY 4.0ImmunologyMedical imaging & radiologyPLOS
  4. Multimodal Insecticidal Activity of α-Humulene Against Chilo suppressalis via Endocrine Disruption and Transcriptional Suppression of Cuticular Proteins
    Zhuo Peng, Wenhui Lu, Yue Meng +13
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Plant biologyCrossref
  5. Identification and characterization of two transmembrane proteins required for virulence of Ustilago maydis
    Paul Weiland, Florian Altegoer
    Frontiers in Plant SciencesPreprintLicence not statedStructural biologyGeneral biologyHAL
BibTeX
@article{arnaudarnould2026snxbar,
  title = {{SNX-BAR proteins 5 and 6 are required for NCOA7-AS antiviral activity against influenza A virus}},
  author = {Mary Arnaud-Arnould and Antoine Rebendenne and Marine Tauziet and Serge Urbach and Khadija El Koulali and Emiliano P Ricci and Mélanie Wencker and Olivier Moncorgé and Mickaël Blaise and Caroline Goujon},
  journal = {Journal of Biological Chemistry},
  year = {2026},
  month = sep,
  doi = {10.1016/j.jbc.2026.113372},
  url = {https://hal.science/hal-05722248v2},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - SNX-BAR proteins 5 and 6 are required for NCOA7-AS antiviral activity against influenza A virus
AU  - Mary Arnaud-Arnould
AU  - Antoine Rebendenne
AU  - Marine Tauziet
AU  - Serge Urbach
AU  - Khadija El Koulali
AU  - Emiliano P Ricci
AU  - Mélanie Wencker
AU  - Olivier Moncorgé
AU  - Mickaël Blaise
AU  - Caroline Goujon
PY  - 2026
DA  - 2026/09/24
JO  - Journal of Biological Chemistry
DO  - 10.1016/j.jbc.2026.113372
UR  - https://hal.science/hal-05722248v2
AB  - Interferon-induced antiviral proteins act on the first line of defence against viruses, including influenza A virus (IAV). Among those, the short isoform of Nuclear Receptor Coactivator 7 (NCOA7-AS) has been shown to inhibit IAV entry and more especially the fusion between endosomal and viral membranes. Ectopic expression of NCOA7-AS leads to the increased acidification of the endolysosomal pathway, putatively through NCOA7-AS interaction with the vacuolar ATPase (V-ATPase). However, the precise mechanism of action of NCOA7-AS is not fully understood. Here, we identified the cellular partners of NCOA7-AS by mass spectrometry, including the V-ATPase subunits known to interact with NCOA7-AS. A point mutation disrupting the interaction with the V-ATPase led to loss of antiviral activity against IAV, demonstrating that V-ATPase engagement is required for the antiviral phenotype. Moreover, sorting nexin (SNX) 1/2/5/6 were identified as novel partners of NCOA7-AS. These proteins are involved in retrograde transport of cellular cargoes from endosomes to the trans-Golgi network. We revealed that SNX5/6 interacted directly with NCOA7-AS and were essential for NCOA7-AS antiviral activity against IAV. Interestingly, crystal structures of NCOA7-AS/SNX5 complexes showed that the SNX5-interaction motif in NCOA7-AS was similar to those found in known cargoes of SNX5/6. In addition, we could pinpoint several critical residues that were important for binding and antiviral activity. Collectively, our study identifies novel essential partners for NCOA7-AS antiviral activity and the structural basis for their interaction.
SN  - 0021-9258
SN  - 1083-351X
ER  -